瑞鬆科技(688090.SH):控股子公司擬在馬來西亞成立合資公司,爲東南亞客戶提供機器人、機器視覺等解決方案
格隆匯5月23日丨瑞鬆科技(688090.SH)公佈,爲進一步完善公司全球化戰略佈局,快速推動海外業務發展進程,有效應對國際形勢變化,拓展國際業務,快速響應客戶需求,加強與國際客戶緊密合作,廣州瑞鬆智能科技股份有限公司的控股子公司廣州瑞鬆北鬥汽車裝備有限公司(簡稱“廣州瑞北”或“控股子公司”)擬與馬來西亞自然人葉城先生在馬來西亞成立合資公司,爲東南亞客戶提供機器人、機器視覺、工業軟件和柔性自動化、數字化、智能製造系統解決方案。新設立公司註冊資本爲300萬林吉特,其中,預計廣州瑞北出資240萬林吉特,佔比80%;預計葉城出資60萬林吉特,佔比20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.